Authors
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Top Meeting Takeaways From the Fall Clinical ConferenceClinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.
Latest:
Psoriasis and Sunburn: New Study Highlights Increased Risk and Clinical ImplicationsSara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.
Latest:
Advances in HS: Insights and Interventions Shared at Annual ConferenceJennifer Hsiao, MD, shares insights on emerging therapies and comprehensive care strategies at the 2024 SDPA Annual Summer Dermatology Conference.
Latest:
Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin DisordersMarcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
Latest:
How to Effectively Partner with Patients to Optimize CareCombined, these efforts encourage active participation in the care process and drive sustained behavior change.
Latest:
AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in VitiligoIncyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.
Latest:
Disseminated Erythema Migrans as a Result of Lyme DiseaseA 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
Latest:
Enhancing Accessibility: Ruxolitinib Cream and Improved Patient AccessLisa Swanson, MD, FAAD, sheds light on the enhanced accessibility of ruxolitinib cream, highlighting its improved availability for patients in need.
Latest:
The Mainstream Patient: January 3, 2023This week's edition of the Mainstream Patient features stories about dry shampoos that don't contain benzene, the best ferulic acid serums, Hijabi hair care, and more.
Latest:
Customization Drives Pediatric Acne Treatment RegimensTreatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.
Latest:
Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of AcneGallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.
Latest:
Proper Coding Gets Practices What They Are OwedA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Latest:
“Apply to Affected Area BID x 2 Weeks Then PRN”Step therapy can delay appropriate care and potentially worsen patients' conditions, writes Dermatology Times Spring Editor in Chief Aaron Farberg, MD.
Latest:
Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent StudyThe study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.
Latest:
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 TherapyChina’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.
Latest:
Patient and Expert Perspectives From the “I LUV YA for the Long Haul” Plaque Psoriasis CampaignOmar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.
Latest:
Improving Representation of Skin of Color in DermatologyMiranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
How a digital front door can improve patients’ access to careOnline-first engagement ensures patients obtain the right care for their specific needs.
Latest:
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MDIn today’s podcast, Silverberg discusses topical therapeutics for vitiligo and clinical excellence.
Latest:
Post-Relapse Treatment of a 50-Year-Old Male Patient with VitiligoContinuing the discussion of a 50-year-old male patient with vitiligo, Anthony Nuara, MD, PhD, addresses the intricacies of treating patients who have relapsed or experienced a loss of efficacy following their initial treatment and highlights how to select 2nd line treatments with greater efficacy.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Sunscreen Protection for ChildrenProtection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.
Latest:
Pointers With Portela: Minimalist Skin Care RoutinesIn this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
Addressing the Health Impacts of a Changing ClimateEthan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.
